UMIN ID: UMIN000054220
Registered date:26/04/2024
The fact-finding survey on Shared Decision Making(SDM)/Measurement Based Care(MBC)in the treatment of depression
Basic Information
Recruitment status | Pending |
---|---|
Health condition(s) or Problem(s) studied | Major depressive disorder |
Date of first enrollment | 2024/06/01 |
Target sample size | 500 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | 1. Tabulation of each answer 2. Tabulation of the following items Cross-tabulation of SDM/MBC implementation and responses of physicians and patients to the following items (content and comprehension of explanations regarding depression treatment, content and comprehension of explanations regarding antidepressants, treatment satisfaction, communication status, comprehension and satisfaction, SDM implementation status and needs, and rating scale use status and needs, etc.) |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 18years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | N/A |
Related Information
Primary Sponsor | other |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Self-funding |
Secondary ID(s) |
Contact
public contact | |
Name | Kazuo Aoki |
Address | Shinagawa Grand Central Tower 2-16-4 Konan, Minato-ku, Tokyo Japan 1088242 |
Telephone | 03-6717-1400 |
aoki.kazuo@otsuka.jp | |
Affiliation | Otsuka Phamacetutical Co., Ltd Department of Medical Affairs |
scientific contact | |
Name | Daisuke Sekine |
Address | Shinagawa Grand Central Tower 2-16-4 Konan, Minato-ku, Tokyo Japan |
Telephone | 03-6717-1400 |
sekined@otsuka.jp | |
Affiliation | Otsuka Phamacetutical Co., Ltd Department of Medical Affairs |